Adult smokers failing to get screened for lung cancer, MGH study says
A study finds only 18% of eligible smokers get lung cancer screenings despite the test being quick and simple. Experts urge ...
Study reveals low lung cancer screening rates among U.S. smokers
A study finds only 18% of eligible U.S. smokers get lung cancer screenings, despite the test being quick and simple. Experts ...
The American Journal of Managed Care3d
PROs Associated With Survival, AEs in Multiple Myeloma
The study highlights the importance of including patient self-assessment—and not just clinician assessment—when planning ...
Dramatic images show the hideous toll microplastics exposure could take on your face
Business Waste used the latest studies to create shocking images that illustrate how high levels of microplastic exposure can ...
BeiGene slips on decision to halt lung cancer program
BeiGene (BGNE) stock falls as the company halts its lung cancer therapy trial after disappointing safety and efficacy data. .
MedPage Today3d
Lung Cancer Screening Rates Nearly 4 Times Lower Than Breast, Colon Cancers
Population-weighted estimates showed that fewer than 18% of eligible patients actually got a low-dose CT scan for lung cancer ...
Science Daily4d
Rates of breast and colorectal cancer screening nearly four-fold higher than lung cancer screening among those eligible
Lung cancer screening has the potential to catch lung cancer early and save lives -- but only if people get screened. Although lung cancer screening is recommended in the U.S. for certain individuals ...
Zacks Investment Research on MSN5d
AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication
AstraZeneca AZN announced that the FDA has approved its blockbuster drug, Imfinzi (durvalumab), for a bladder cancer ...
Stocktwits on MSN10d
Candel’s Final Survival Data From Lung Cancer Drug Trial Lifts Stock After-Hours, Fuels Retail Optimism
Candel Therapeutics Inc. stock ended Wednesday deep in the red but rose 1.3% in extended trading after the company announced ...
UNILAD14d
Risk of prostate cancer increases by 45% in men who share one common practice
New research shows the risk of prostate cancer increases by 45 percent in men who share one common practice. According to the ...
Cure Today14d
Unraveling Disparities and Genomic Advances Across Breast Cancer Care
Genomic testing is pivotal in refining breast cancer treatment strategies, particularly for African American women facing unique diagnostic challenges. Tests like MAMMAPRINT analyze numerous genes, ...